BCM
FBRX icon

Bridgeway Capital Management’s Forte Biosciences FBRX Stock Holding History

Bridgeway Capital Management’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,475
Closed -$38.3K – 1390
2023
Q2 		$38.3K Hold
1,475
– – ﹤0.01% 1346
2023
Q1 		$37.2K Hold
1,475
– – ﹤0.01% 1331
2022
Q4 		$36.9K Hold
1,475
– – ﹤0.01% 1320
2022
Q3 		$39K Sell
1,475
-2,000
-58% -$63.5K ﹤0.01% 1363
2022
Q2 		$113K Hold
3,475
– – ﹤0.01% 1206
2022
Q1 		$127K Buy
+3,475
New +$131K ﹤0.01% 1239
2021
Q2 		– Sell
-253
Closed -$217K – 1356
2021
Q1 		$217K Hold
253
– – ﹤0.01% 1278
2020
Q4 		$230K Hold
253
– – ﹤0.01% 1179
2020
Q3 		$307K Buy
+253
New +$168K 0.01% 1056
2020
Q2 		– Sell
-35
Closed -$16K – 1329
2020
Q1 		$16K Hold
35
– – ﹤0.01% 1254
2019
Q4 		$7K Sell
35
-150
-81% -$34K ﹤0.01% 1301
2019
Q3 		$46K Sell
185
-85
-31% -$129K ﹤0.01% 1277
2019
Q2 		$676K Sell
270
-40
-13% -$119K 0.01% 878
2019
Q1 		$1.26M Buy
310
+36
+13% +$139K 0.02% 677
2018
Q4 		$844K Hold
274
– – 0.01% 796
2018
Q3 		$1.6M Buy
274
+7
+3% +$26.6K 0.02% 700
2018
Q2 		$934K Hold
267
– – 0.01% 897
2018
Q1 		$1.19M Hold
267
– – 0.01% 793
2017
Q4 		$1.02M Buy
+267
New +$1.07M 0.01% 839

Other funds holding FBRX

TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bridgeway Capital Management's FBRX Position: Q3 2023 in Review

Bridgeway Capital Management sold out of Forte Biosciences (FBRX) in Q3 2023, closing a stake of 1,475 shares — an estimated $38.3K sold.

Bridgeway Capital Management first reported a position in FBRX in Q4 2017 and held it in 19 quarters. The position peaked at $1.6M in Q3 2018. 30 funds tracked by Wall St. Rank hold FBRX as of Q3 2023.

  • Bridgeway Capital Management reported no remaining Forte Biosciences position as of Q3 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 1,475 Forte Biosciences shares in Q3 2023, an estimated $38.3K.
  • Bridgeway Capital Management first reported a position in Forte Biosciences in Q4 2017 and held it in 19 quarters.
  • Bridgeway Capital Management's Forte Biosciences position peaked at $1.6M in Q3 2018.
  • 30 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.